Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.3K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

964
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
964
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal asthma activity and offspring asthma: a linked-data population study in Australia and Sweden.

BMJ open respiratory research·2026
Same author

Treatable Traits for Asthma Management in Pregnancy (TTAP): protocol for an Australian multicentre prospective observational cohort study.

BMJ open·2026
Same author

Early-life lung function deficits partially explain the link between maternal asthma and bronchiolitis or asthma in offspring.

BMJ open respiratory research·2026
Same author

Dog exposure and subsequent asthma outcomes in children with asthma and allergy.

The journal of allergy and clinical immunology. Global·2026
Same author

Maternal asthma and the role of stress, sensitization, and lung function on pregnancy outcomes: MAESTRO cohort study.

The journal of allergy and clinical immunology. Global·2026
Same author

Biphasic Effects on Allergen-Specific Type 2 Memory B Cells Over 18 Months Sublingual Immunotherapy for House Dust Mite Allergy.

Allergy·2026

Related Experiment Video

Updated: Jan 15, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.4K

Asthma in Pregnancy.

Eve Denton1,2, Megan E Jensen3, Bronwyn K Brew3

  • 1Asthma, Allergy and Clinical Immunology, The Alfred Hospital, Melbourne, Victoria, Australia.

Allergy
|October 6, 2025
PubMed
Summary
This summary is machine-generated.

Asthma affects pregnant women, with respiratory changes impacting its severity unpredictably. Uncontrolled asthma increases risks for mothers and babies, highlighting the need for safe treatment options during pregnancy.

Keywords:
asthmaepidemiologypregnancytreatable traitstreatment

More Related Videos

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

41.2K
Acupuncture in a Rat Model of Asthma
07:14

Acupuncture in a Rat Model of Asthma

Published on: August 25, 2020

6.5K

Related Experiment Videos

Last Updated: Jan 15, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.4K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

41.2K
Acupuncture in a Rat Model of Asthma
07:14

Acupuncture in a Rat Model of Asthma

Published on: August 25, 2020

6.5K

Area of Science:

  • Obstetrics and Gynecology
  • Pulmonology
  • Clinical Immunology

Background:

  • Asthma is a prevalent chronic respiratory condition in pregnant individuals.
  • Pregnancy induces significant physiological respiratory changes, affecting asthma control variably.
  • Uncontrolled asthma during pregnancy is linked to adverse maternal and fetal outcomes.

Purpose of the Study:

  • To review current evidence on asthma epidemiology in pregnancy.
  • To discuss pregnancy-related respiratory alterations and their impact on asthma.
  • To explore comorbidities and treatment strategies for asthma during gestation.

Main Methods:

  • Literature review of epidemiological data.
  • Analysis of physiological changes in the respiratory system during pregnancy.
  • Examination of comorbidity prevalence and impact.
  • Assessment of current and emerging asthma treatment options.

Main Results:

  • Asthma prevalence varies globally in pregnant populations.
  • Respiratory system modifications during pregnancy can unpredictably alter asthma status.
  • Medication non-adherence due to safety concerns is a key factor in asthma control loss.
  • Metabolic comorbidities are increasingly recognized as significant factors in asthma and pregnancy outcomes.
  • Observational data suggest potential safety for biologics like omalizumab and dupilumab, though further research is required.

Conclusions:

  • Effective asthma management during pregnancy is crucial for optimizing maternal and fetal health.
  • Addressing medication adherence and comorbidities is essential for maintaining asthma control.
  • Further research is needed to confirm the safety and efficacy of specific asthma therapies in pregnant women.